VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2021 | IMW 2021: MRD highlights

Daniel Auclair, PhD, of the Multiple Myeloma Research Foundation (MMRF), Norwalk, CT, gives an overview of the key updates on the use of measurable residual disease (MRD) in myeloma, as presented at the IMW 2021 meeting, and discusses updates and sessions which will take place at the upcoming MMRF MRD Meeting on October 13th. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter